Quantcast

Latest National Institute for Health and Clinical Excellence Stories

2008-06-30 06:02:49

By Kate Foster; Louisa Pearson MARY DUNN remembers only too well what nursing was like in Scotland in the early days of the NHS: diphtheria and tuberculosis, long shifts and hours spent shining the floors. That sharp contrast to today, as the NHS prepares to celebrate its 60th anniversary, shows just how far healthcare has come. Controversies rage daily about funding, cleanliness and quality of care in the modern service, but Dunn provides a useful historical context. "I remember...

2008-06-26 12:02:13

The National Health Service is said to be in quandary over its practice of excluding patients who seek private treatment, especially for cancer, according to Financial Times. The National Health Service (NHS) has long had a policy that patients who spend their own money for expensive drugs that aren't reimbursed by the government automatically become private-pay customers who have to pay the whole bill. But owing to pressure from patients and advocacy groups the UK government has agreed to...

2008-06-26 00:01:07

A controversial weight-loss drug has been approved for use on the NHS, it was announced today. Rimonabant will be made available to overweight or obese patients who cannot take, or who have had no success with, two other drugs, orlistat and sibutramine. It comes after concerns about rimonabant's side-effects, including suicidal thoughts and depression. Today's news comes after the medicines watchdog said last month that it had received 720 reports of adverse drug reactions (totalling...

2008-06-25 12:03:12

The National Institute for Health and Clinical Excellence has recommended adalimumab as a treatment option for adults with severe chronic plaque psoriasis. The National Institute for Health and Clinical Excellence (NICE) has recommended adalimumab as a treatment option for adults with plaque psoriasis for whom anti-tumour necrosis factor treatment is being considered and when the following criteria are both met: The disease is severe as defined by a total Psoriasis Area Severity Index of 10...

2008-06-24 18:01:40

By John Rentoul Old Labour practices live on in the cruel rule that prevents NHS patients paying for extra cancer treatment Once upon a time, at the very beginning of New Labour, before it was even called New Labour, Neil Kinnock made the speech of his life that would change politics. He spoke of impossible promises - he meant those of the Trotskyist left, but he could have been talking of any utopianism. "They are then pickled into a rigid dogma, a code, and you go through the years...

2008-06-19 00:00:29

Ministers yesterday announced a review of a controversial policy which denies patients NHS treatment if they top up their care privately. The decision comes in the face of legal action by patients including cancer sufferer Colette Mills, of Stokesley, North Yorkshire, which aims to overturn a ban on co-payments that leaves people at risk of losing NHS treatment if they also pay for private care. The issue has come under sharper focus following the death of bowel cancer patient Linda...

2008-06-18 09:01:16

By Jeremy Laurance Health Editor Ministers have bowed to public and political pressure and performed a U-turn over rules denying NHS patients the right to top up their care with treatment paid for privately. Alan Johnson, the Health Secretary, announced a review yesterday of the current policy which requires patients who choose to buy drugs not available on the NHS to pay the whole cost of their care. The Government had come under pressure from cancer patients demanding the right to buy...

2006-09-01 08:31:41

LONDON (Reuters) - Memory clinics and drugs to slow the progress of symptoms of Alzheimer's disease are diverting resources in Britain's state-funded health services from high quality integrated care, doctors said on Friday. The treatments known as cholinesterase inhibitors have been recommended by the country's cost-effectiveness watchdog, the National Institute for Health and Clinical Excellence (NICE), for patients with mild-to-moderate Alzheimer's disease since 2001. But...

2006-08-21 03:00:43

LONDON (Reuters) - Two new targeted therapies for bowel cancer should not be used on Britain's state-run health service, the country's cost-effectiveness watchdog NICE said on Monday. The recommendation angered patient groups, since both Avastin and Erbitux are widely available in the United States and much of Europe. The National Institute for Health and Clinical Excellence (NICE), however, decided the high cost of the medicines meant their use was not "compatible with the best use...

2005-06-14 18:45:14

Health professionals led by a cancer specialist from the University of Edinburgh have put forward the case for finding new and fairer ways to assess the value of treatments for patients who will eventually die from their condition. Writing in the current edition of the British Medical Journal (10 June, 2005) the experts argue that this issue should be explored because of its impact on national decisions about which new treatments are funded. Lead author of the BMJ article, Dr Ross Camidge,...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related